HIGHLIGHTS
- who: TLRs and colleagues from the Yonsei University, South Korea Chinese Medicine, China have published the article: NLRP3 neuroin fl ammatory factors may be involved in atopic dermatitis mental disorders: an animal study, in the Journal: (JOURNAL)
- what: Based on the NLRP3 inflammasome, not only can the authors provide more potential therapeutic targets such as co-therapy for AD with anxiety and depression but also provide a reference for exploring new drugs for AD therapy. Currently, the main purposes of AD treatment are to alleviate or eliminate clinical symptoms, eliminate triggers and/or aggravating factors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.